LinkedIn Profile

Access Abide Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:abidetherapeutics 8677950 Jun 7th, 2019 12:00AM Abide Therapeutics 725 46.00 Open Biotechnology Jun 7th, 2019 08:34AM Jun 7th, 2019 08:34AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 6th, 2019 12:00AM Abide Therapeutics 726 46.00 Open Biotechnology Jun 6th, 2019 12:34PM Jun 6th, 2019 12:34PM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 5th, 2019 12:00AM Abide Therapeutics 727 46.00 Open Biotechnology Jun 5th, 2019 09:27AM Jun 5th, 2019 09:27AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 4th, 2019 12:00AM Abide Therapeutics 727 47.00 Open Biotechnology Jun 4th, 2019 08:23AM Jun 4th, 2019 08:23AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 3rd, 2019 12:00AM Abide Therapeutics 727 47.00 Open Biotechnology Jun 3rd, 2019 08:30AM Jun 3rd, 2019 08:30AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 2nd, 2019 12:00AM Abide Therapeutics 726 47.00 Open Biotechnology Jun 2nd, 2019 10:18AM Jun 2nd, 2019 10:18AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 Jun 1st, 2019 12:00AM Abide Therapeutics 726 47.00 Open Biotechnology Jun 1st, 2019 02:00PM Jun 1st, 2019 02:00PM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 May 31st, 2019 12:00AM Abide Therapeutics 726 47.00 Open Biotechnology May 31st, 2019 08:36AM May 31st, 2019 08:36AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 May 30th, 2019 12:00AM Abide Therapeutics 724 47.00 Open Biotechnology May 30th, 2019 12:54PM May 30th, 2019 12:54PM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology
private:abidetherapeutics 8677950 May 29th, 2019 12:00AM Abide Therapeutics 722 47.00 Open Biotechnology May 29th, 2019 10:25AM May 29th, 2019 10:25AM Abide Therapeutics is a clinical-stage biotechnology company committed to realizing the therapeutic value of first-in-class serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs. Our initial therapeutic focus is on novel targets involved in central nervous system signaling pathways. The 250 enzymes in the serine hydrolase superfamily represent roughly 1% of the human genome and play key roles in physiology and disease. Our platform allows us to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from our proprietary and tailored chemical library. Our world-class team is driven by knowing that the work we do today will change patients'​ lives tomorrow. Abide is located in Princeton, NJ and La Jolla, CA. For more information, please visit www.abidetx.com. Open Biotechnology, Small molecule drugs, Serine hydrolase inhibitors, CNS disorders, Neurodegeneration Open 10835 Road to the Cure #250 San Diego California US 92121 Abide Therapeutics Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.